Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease

Introduction : Deep remission, defined as clinical remission with mucosal healing (MH), with anti-tumor necrosis factor (TNF)-α agents is a new target for therapy in Crohn’s disease (CD). Provided that the efficacy of infliximab (IFX) for induction of MH in CD has been demonstrated, there are much l...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Edyta Szymanska, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, Jaroslaw Kierkus
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2016-12-01
Serija:Gastroenterology Review
Teme:
adalimumab
deep remission
mucosal healing
Crohn’s disease
Online dostop:https://www.termedia.pl/Adalimumab-for-endoscopic-and-histopathological-mucosal-healing-in-paediatric-patients-with-moderate-to-severe-Crohn-s-disease,41,28947,1,1.html
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki